Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- AIFORIA.HE
- Price
- 2.36
- Stock movement down
- -0.09 (-3.81%)
- Company name
- Aiforia Technologies Oyj
- Exchange
- (HE ,
- Currency
- EUR )
- Sector
- Healthcare >Health Information Services
- Market cap
- 76.29M
- Ent value
- 76.21M
- Price/Sales
- 13.33
- Price/Book
- 4.04
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -35.51%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2026-01-19
DIVIDENDS
AIFORIA.HE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 13.33 |
| Price to Book | 4.04 |
| EV to Sales | 13.31 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 33.61M |
| EPS (TTM) | -0.80 |
| FCF per share (TTM) | -1.33 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 5.72M |
| Gross profit (TTM) | 4.38M |
| Operating income (TTM) | -24.30M |
| Net income (TTM) | -25.24M |
| EPS (TTM) | -0.80 |
| EPS (1y forward) | -0.26 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 76.54% |
| Operating margin (TTM) | -424.37% |
| Profit margin (TTM) | -440.80% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 11.87M |
| Net receivables | 470.00K |
| Total current assets | 14.10M |
| Goodwill | 0.00 |
| Intangible assets | 15.28M |
| Property, plant and equipment | 974.00K |
| Total assets | 30.67M |
| Accounts payable | 2.56M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 4.96M |
| Total liabilities | 11.79M |
| Shareholder's equity | 18.88M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -24.09M |
| Capital expenditures (TTM) | 17.93M |
| Free cash flow (TTM) | -42.01M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -133.69% |
| Return on Assets | -82.28% |
| Return on Invested Capital | -104.54% |
| Cash Return on Invested Capital | -174.04% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.30 |
| Daily high | 2.32 |
| Daily low | 2.25 |
| Daily Volume | 36K |
| All-time high | 5.53 |
| 1y analyst estimate | 3.50 |
| Beta | 0.21 |
| EPS (TTM) | -0.80 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AIFORIA.HE | S&P500 | |
| Current price drop from All-time high | -57.32% | -0.50% |
| Highest price drop | -59.31% | -19.00% |
| Date of highest drop | 16 Dec 2025 | 8 Apr 2025 |
| Avg drop from high | -40.61% | -2.50% |
| Avg time to new high | - | 6 days |
| Max time to new high | 316 days | 89 days |
COMPANY DETAILS
Marketcap
76.29M
Marketcap category
Small-cap
Description
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application. The company's products are used for the treatment of Parkinson's disease, organ transplantation, and liver and inflammatory bowel diseases. It serves academic institutes and pharmaceutical companies through direct and sales partners. The company was incorporated in 2013 and is headquartered in Helsinki, Finland.
Employees
73
Website
Investor relations
-
SEC filings
CEO
Country
Finland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found